E. Thiel

10.4k total citations · 2 hit papers
208 papers, 6.9k citations indexed

About

E. Thiel is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, E. Thiel has authored 208 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 53 papers in Oncology and 52 papers in Genetics. Recurrent topics in E. Thiel's work include Acute Lymphoblastic Leukemia research (48 papers), Lymphoma Diagnosis and Treatment (38 papers) and Acute Myeloid Leukemia Research (35 papers). E. Thiel is often cited by papers focused on Acute Lymphoblastic Leukemia research (48 papers), Lymphoma Diagnosis and Treatment (38 papers) and Acute Myeloid Leukemia Research (35 papers). E. Thiel collaborates with scholars based in Germany, United States and Austria. E. Thiel's co-authors include Stefan Schwartz, D. Hoelzer, Agnieszka Korfel, H. Rodt, H. Löffler, S. Thierfelder, Peter Martus, Patricia Ribaud, Nöel Milpied and Raoul Herbrecht and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

E. Thiel

204 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

2002 643 citations E. Thiel et al. profile →
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

1988 430 citations D. Hoelzer, E. Thiel et al. profile →

Peers

Countries citing papers authored by E. Thiel

Since Specialization

Citations

This map shows the geographic impact of E. Thiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Thiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Thiel more than expected).

Fields of papers citing papers by E. Thiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Thiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Thiel. The network helps show where E. Thiel may publish in the future.

Co-authorship network of co-authors of E. Thiel

This figure shows the co-authorship network connecting the top 25 collaborators of E. Thiel. A scholar is included among the top collaborators of E. Thiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Thiel. E. Thiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG 2011 ·Oncogene ·Liliana H. Mochmann, (unknown), Jutta Ortiz-Tánchez, Cornelia Schlee, (unknown), Konrad Neumann, W.‐K. Hofmann, E. Thiel, Claudia D. Baldus	35
2	Meningeal dissemination in primary CNS lymphoma 2008 ·Neurology ·L. Fischer, Peter Martus, Michael Weller, H. Klasen, (unknown), Alexander Röth, Benjamin Storek, Michael Hummel, Thomas Nägele, E. Thiel, Agnieszka Korfel	67
3	Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management 2008 ·Annals of Oncology ·Olaf Penack, (unknown), Barbara Graf, Igor Wolfgang Blau, E. Thiel	46
4	Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report 2007 ·Annals of Oncology ·Sean Grimm, José S. Pulido, Kristoph Jahnke, David Schiff, Anthony Hall, Tamara Shenkier, T. Siegal, Nancy D. Doolittle, Tracy T. Batchelor, Ulrich Herrlinger, Edward A. Neuwelt, Normand Laperrière, Marc C. Chamberlain, Jean‐Yves Blay, Andrés J.M. Ferreri, Antonio Omuro, E. Thiel, Lauren E. Abrey	188
5	Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures 2007 ·Annals of Oncology ·Olaf Penack, (unknown), Martin Eisenblätter, Andrea Stroux, J. Wagner, E. Thiel, Igor Wolfgang Blau	21
6	Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations 2006 ·Leukemia ·Thomas Burmeister, Rolf Marschalek, Björn Schneider, Claus Meyer, Nicola Gökbuget, Stefan Schwartz, D. Hoelzer, E. Thiel	40
7	A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma 2006 ·Annals of Oncology ·Alexander Schmittel, Martin Schmidt‐Hieber, Peter Martus, (unknown), R. Schuster, (unknown), M. H. Foerster, E. Thiel, Ulrich Keilholz	62
8	High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma 2005 ·Annals of Oncology ·Kristoph Jahnke, Agnieszka Korfel, Peter Martus, Michael Weller, Ulrich Herrlinger, Alexander Schmittel, L. Fischer, E. Thiel	87
9	Allogeneic hematopoietic cell transplantation following conditioning with⁹⁰Y-ibritumomab-tiuxetan 2005 ·Leukemia & lymphoma ·Thomas Fietz, L. Uharek, Chiara Gentilini, (unknown), Kathrin Rieger, (unknown), D. Sandrock, D. L. Munz, B. Glaß, E. Thiel, Igor Wolfgang Blau	23
10	Phase I Dose Escalation Study of Carboplatin to a Fixed Dose of Irinotecan as First-Line Treatment of Small Cell Lung Cancer 2004 ·Oncology Research and Treatment ·Alexander Schmittel, K. Schulze, Gero Hütter, (unknown), E. Thiel, Ulrich Keilholz	8
11	Stem cell mobilization in multiple myeloma patients: Do we need an age‐adjusted regimen for the elderly? 2004 ·Journal of Clinical Apheresis ·Thomas Fietz, Kathrin Rieger, Fernando Dimeo, Igor Wolfgang Blau, E. Thiel, Wolfgang Knauf	25
12	Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10−/CD24−/CD65s+/CD15+ B-cell phenotype 2003 ·Leukemia ·Stefan Schwartz, Harald Rieder, (unknown), Thomas Burmeister, L. Fischer, E. Thiel	75
13	Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation 2001 ·Clinical & Laboratory Haematology ·Beate Gleissner, IW Blau, (unknown), Richard Reinhardt, Wolfgang Knauf, E. Thiel	3
14	Nested Quantitative Real Time PCR for Detection of Occult Tumor Cells 2001 ·Recent results in cancer research ·Nicole Max, (unknown), Benjamin T. Spike, E. Thiel, Ulrich Keilholz	15
15	High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia 1998 ·Leukemia ·Harald Rieder, (unknown), (unknown), J. Mäurer, (unknown), Stefan Schwartz, W-D Ludwig, W. Gaßmann, (unknown), E. Thiel, H. Löffler, Nicola Gökbuget, D. Hoelzer, Christa Fonatsch	29
16	Cryptococcosis in Hodgkin's disease: description of two cases and review of the literature 1998 ·Annals of Hematology ·A. Korfel, (unknown), Stefan Schwartz, E. Thiel	30
17	Quantifying Cell Adhesion of the Colon Cancer Cell Line HT 29 to Extracellular Matrix Proteins: Comparative Evaluation of an Isotopic, a Fluorometric, and a Colorimetric Method 1994 ·Oncology Research and Treatment ·(unknown), Michael Streit, E.D. Kreuser, Ute Harms, J Schulz, Ulrich Mansmann, E. Thiel, W. E. Berdel	1
18	lnterferon-alpha2b for Early Phase Chronic Lymphocytic Leukemia with High Risk for Progression – First Results of a Randomized Multicenter AlO-Study 1992 ·Oncology Research and Treatment ·Wolfgang Knauf, (unknown), C. Nerl, Hermann Dietzfelbinger, P. Maubach, H.W.L. Ziegler-Heitbrock, Bertold Emmerich, E. Thiel	1
19	Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction 1991 ·The Lancet ·J. Mäurer, E. Thiel, (unknown), (unknown), (unknown), B Heinze, J van Denderen, Ü. Aydemir, Christa Fonatsch, Jochen Harbott, Alfred Reiter, (unknown), (unknown)	185
20	[Immunohistochemical findings in malignant lymphatic system diseases]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·D. Huhn, H. Rodt, E. Thiel, G.J. Jager	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact